Rho is adept at managing every aspect of Phase II and Phase III trials. We offer a broad range of services that allows us to provide capacity and experience in clinical trial management.
Clinical operations provides experience and leadership at each site
The value of Rho's Clinical Operations lies in the experience we bring to the client. As a result, we can provide strong site management and enrollment strategies. We consider the Lead Clinical Research Associate (LCRA) to be an integral part of the study—that's why ours have an average of 5 to 10 years of clinical operations leadership experience. Our regional CRA model allows us to provide hands-on coverage to all regions of the country.
Medical monitoring services with a focus on safety
Rho's Medical Monitors are a vital component to Phase II and Phase III clinical trial success. Medical monitoring plays an important role in providing protection to research subjects, integrity of results, and consistency of protocol. Our team of Medical Monitors is composed of an on-board staff and worldwide network of specialist physicians that guide study teams through the issues faced in clinical research studies.
Robust statistical services and advice
Our creative statisticians design small yet flexible Phase II studies. We critically review Phase II results, investigate data accuracy, and conduct power analyses when designing larger Phase III studies. Our statisticians support data and safety monitoring boards (DSMBs) and conduct interim analyses. Because timing is so critical in these phases of development, our counsel can help you make timely and informed decisions about sample sizes and doses, which will guide your program development.
Clinical data management capacity
Phase II and Phase III studies require strong capabilities to handle a large volume of sites, subjects, and case report forms (eCRFs or CRFs). Rho delivers the clinical data management capacity necessary for these vital phases of development. We've demonstrated this strength in successfully completed projects with hundreds of sites and thousands of subjects.
Discover Rho's expertise in Phase II and Phase III trials
Many of the world's leading health care companies and federal research institutes choose Rho because of our strength in Phase II and Phase III services. Discover more of the strengths that distinguish Rho from other CROs as you continue through this section.